Rockwell Medical (RMTI) Current Assets (2010 - 2026)
Rockwell Medical (RMTI) posted Current Assets of $36.9 million for Q1 2026, down 3.2% on a QoQ basis from $38.2 million in Q4 2025, and up 11.83% year-over-year from $33.0 million in Q1 2025.
Rockwell Medical (RMTI) Current Assets (2010 - 2026) Analysis & Trends
Rockwell Medical's Current Assets history runs 17 years deep, the most recent figure standing at $36.9 million for Q1 2026.
- Quarterly Current Assets rose 11.83% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.9 million (up 11.83% YoY) and the FY2025 annual result came in at $38.2 million, up 3.06% from the prior year.
- Current Assets was $36.9 million for Q1 2026 at Rockwell Medical, down from $38.2 million in the prior quarter.
- Across five years, Current Assets topped out at $47.2 million in Q2 2022 and bottomed at $24.8 million in Q1 2022.
- A 5-year average of $33.5 million and a median of $33.0 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets tumbled 58.14% — and 2024, when it increased 28.71%.
- Rockwell Medical's Current Assets stood at $35.3 million in 2022, then decreased by 18.52% to $28.8 million in 2023, then advanced by 28.71% to $37.0 million in 2024, then climbed by 3.06% to $38.2 million in 2025, then retreated by 3.2% to $36.9 million in 2026.
- Business Quant data shows RMTI's Current Assets at $36.9 million in Q1 2026, $38.2 million in Q4 2025, and $37.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 36.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.94 Mn |
| Dec 31, 2025 | 38.16 Mn |
| Sep 30, 2025 | 37.51 Mn |
| Jun 30, 2025 | 31.61 Mn |
| Mar 31, 2025 | 33.03 Mn |
| Dec 31, 2024 | 37.03 Mn |
| Sep 30, 2024 | 34.22 Mn |
| Jun 30, 2024 | 29.75 Mn |
| Mar 31, 2024 | 26.70 Mn |
| Dec 31, 2023 | 28.77 Mn |
| Sep 30, 2023 | 28.17 Mn |
| Jun 30, 2023 | 27.57 Mn |
| Mar 31, 2023 | 29.69 Mn |
| Dec 31, 2022 | 35.31 Mn |
| Sep 30, 2022 | 42.36 Mn |
| Jun 30, 2022 | 47.25 Mn |
| Mar 31, 2022 | 24.80 Mn |
| Dec 31, 2021 | 35.29 Mn |
| Sep 30, 2021 | 46.08 Mn |
| Jun 30, 2021 | 52.40 Mn |